We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

193 hedge funds and large institutions have $581M invested in Sage Therapeutics in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 54 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

363% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $2.18M

41% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 54

5% less funds holding

Funds holding: 204 → 193 (-11)

8.37% less ownership

Funds ownership: 97.3% → 88.92% (-8.4%)

20% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 40

47% less capital invested

Capital invested by funds: $1.1B → $581M (-$516M)

Holders
193
Holders Change
-11
Holders Change %
-5.39%
% of All Funds
2.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
76
Reduced
54
Closed
40
Calls
$10.1M
Puts
$2.18M
Net Calls
+$7.92M
Net Calls Change
+$5.82M

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$11.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$8.59M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.52M
4
Invesco
Invesco
Georgia
+$7.38M
5
Renaissance Technologies
Renaissance Technologies
New York
+$6.64M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$60.4M
2
State Street
State Street
Massachusetts
-$25.9M
3
Deutsche Bank
Deutsche Bank
Germany
-$12.9M
4
SC
Samlyn Capital
New York
-$11.1M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
HSBC Holdings
201
HSBC Holdings
United Kingdom
– -$1.57M -83,577 Closed
Canada Pension Plan Investment Board
202
Canada Pension Plan Investment Board
Ontario, Canada
– -$1.19M -63,300 Closed
CANY
203
Caxton Associates (New York)
New York
– -$1.04M -55,745 Closed
CCIA
204
Campbell & Co Investment Adviser
Maryland
– -$923K -49,274 Closed
SEC
205
Seven Eight Capital
New York
– -$853K -45,494 Closed
Simplex Trading
206
Simplex Trading
Illinois
– -$486K -37,954 Closed
AIG
207
American International Group
New York
– -$488K -26,055 Closed
NYLIM
208
New York Life Investment Management
New York
– -$359K -19,151 Closed
EFM
209
E Fund Management
China
– -$348K -18,544 Closed
Principal Financial Group
210
Principal Financial Group
Iowa
– -$262K -13,976 Closed
Handelsbanken Fonder
211
Handelsbanken Fonder
Sweden
– -$259K -13,844 Closed
Teacher Retirement System of Texas
212
Teacher Retirement System of Texas
Texas
– -$225K -12,027 Closed
ACM
213
Aquatic Capital Management
Illinois
– -$216K -11,500 Closed
AC
214
AXQ Capital
New Jersey
– -$198K -10,570 Closed
SPA
215
Sherbrooke Park Advisers
New York
– -$188K -10,058 Closed
VF
216
Virtu Financial
New York
– -$187K -10,003 Closed
PHK
217
Point72 Hong Kong
Hong Kong
– -$62.3K -3,325 Closed
MLICM
218
Metropolitan Life Insurance Company (MetLife)
New York
– -$56.8K -3,029 Closed
CFM
219
Catalyst Funds Management
Australia
– -$30K -1,600 Closed
KBC Group
220
KBC Group
Belgium
– -$24K -1,282 Closed
CIA
221
Cape Investment Advisory
Georgia
– -$9.37K -500 Closed
NC
222
nVerses Capital
Florida
– -$7.5K -400 Closed
FIM
223
Fernwood Investment Management
Massachusetts
– -$3.17K -169 Closed
N
224
Natixis
France
– -$1.78K -95 Closed
MPWT
225
MassMutual Private Wealth & Trust
Connecticut
– -$1.65K -88 Closed
6 7 8
9
10

SAGE Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q2 2024, worth a combined $581M — down 47% from $1.1B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of SAGE and 32 opened new positions — a net loss of 8 holders — while 54 trimmed existing stakes and 76 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $11.1M. The largest seller was Wellington Management Group, cutting an estimated $60.4M.

  • 193 institutional investors held Sage Therapeutics (SAGE) as of Q2 2024, down from 204 in Q1 2024.
  • Funds reported $581M of Sage Therapeutics stock for Q2 2024, down 47% quarter-over-quarter.
  • 32 funds opened new Sage Therapeutics positions in Q2 2024 and 40 closed out, a net change of -8 holders.
  • The largest Sage Therapeutics buyer in Q2 2024 was Jacobs Levy Equity Management, an estimated $11.1M added.
  • The largest Sage Therapeutics seller in Q2 2024 was Wellington Management Group, an estimated $60.4M sold.

Based on aggregated 13F filings for Q2 2024.